Christopher Mutz insider trades
Open-market stock purchases and sales by Christopher Mutz, HEAD OF RARE DISEASE at ANI Pharmaceuticals Inc, from SEC Form 4 filings since Feb 15, 2021.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Mar 13, 2026 | ANIP ANI Pharmaceuticals Inc | Sold | $227K |
| Mar 9, 2026 | ANIP ANI Pharmaceuticals Inc | Sold | $267K |
| Mar 7, 2026 | ANIP ANI Pharmaceuticals Inc | Sold (not open market) | $245K |
| Mar 6, 2026 | ANIP ANI Pharmaceuticals Inc | Sold | $157K |
| Mar 2, 2026 | ANIP ANI Pharmaceuticals Inc | Sold | $30.9K |
| Feb 28, 2026 | ANIP ANI Pharmaceuticals Inc | Sold (not open market) | $164K |
| Feb 26, 2026 | ANIP ANI Pharmaceuticals Inc | Bought (not open market) | $1.6M |
| Feb 20, 2026 | ANIP ANI Pharmaceuticals Inc | Sold | $415K |
| Feb 14, 2026 | ANIP ANI Pharmaceuticals Inc | Sold (not open market) | $186K |
| Feb 12, 2026 | ANIP ANI Pharmaceuticals Inc | Sold (not open market) | $243K |
| Feb 12, 2026 | ANIP ANI Pharmaceuticals Inc | Sold | $538K |
| Feb 11, 2026 | ANIP ANI Pharmaceuticals Inc | Sold (not open market) | $347K |
Companies traded
- ANIP ANI Pharmaceuticals Inc: 11 sales, last Mar 13, 2026